Manufacturer of Controlled Substances Registration: Siegfried USA, LLC, 42539 [2015-17520]

Download as PDF 42539 Federal Register / Vol. 80, No. 137 / Friday, July 17, 2015 / Notices Operations Industry Consortium, Inc. (‘‘NCOIC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Military Communication Institute, Zegrze, Mazowieckie, POLAND; and Real-Time Innovation, Sunnyvale, CA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and NCOIC intends to file additional written notifications disclosing all changes in membership. On November 19, 2004, NCOIC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on February 2, 2005 (70 FR 5486). The last notification was filed with the Department on March 25, 2015. A notice was published in the Federal Register pursuant to section 6(b) of the Act on April 22, 2015 (80 FR 22550). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2015–17543 Filed 7–16–15; 8:45 am] BILLING CODE P Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. DEPARTMENT OF JUSTICE Antitrust Division [FR Doc. 2015–17545 Filed 7–16–15; 8:45 am] srobinson on DSK5SPTVN1PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—UHD Alliance, Inc., in Its Capacity as a Standards Development Organization Notice is hereby given that, on June 17, 2015, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), UHD Alliance, Inc., in its capacity as a Standards Development Organization (‘‘UHD Alliance SDO’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the name and principal place of business of the standards development organization and (2) the nature and scope of its standards development activities. The notifications were filed for the purpose of invoking the Act’s provisions limiting VerDate Sep<11>2014 20:59 Jul 16, 2015 the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to section 6(b) of the Act, the name and principal place of business of the standards development organization is: UHD Alliance, Inc., Fremont, CA. The nature and scope of UHD Alliance SDO’s standards development activities are as follows: UHD Alliance SDO is organized and will be operated primarily to create a framework to enable the global industries interested in premium next generation content related technologies, such as Ultra High Definition, High Dynamic Range, Wide Color Gamut, High Frame Rate and Next Gen Audio (‘‘Premium Next Gen Content’’) to (a) specify and develop requirements for the premium quality Premium Next Gen Content, related devices, distribution and other elements of a UHD Alliance-based ecosystem (‘‘Specifications’’); (b) promote the global development and adoption of Specifications and Specificationcompliant products (i.e., content, devices, and services); (c) provide clear definitions, industry guidelines and best practices on emerging technologies and collaborate with other standards development organizations; (d) develop and administer Premium Next Gen Content testing methodologies and certification programs based on the Specifications; (e) establish a logo program for Specification certified products (i.e., content, devices and services); and (f) promote the UHD Alliance brand and ecosystem to consumers. Jkt 235001 BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Siegfried USA, LLC ACTION: Notice of registration. Siegfried USA, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Siegfried USA, LLC registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated February 5, 2015, and published SUMMARY: PO 00000 Frm 00073 Fmt 4703 Sfmt 9990 in the Federal Register on February 11, 2015, 80 FR 7634, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siegfried USA, LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Gamma Hydroxybutyric Acid (2010). Dihydromorphine (9145) ............... Hydromorphinol (9301) ................. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone intermediate (9254) ... Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Opium tincture (9630) .................. Oxymorphone (9652) ................... Schedule I I I II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Dated: July 10, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015–17520 Filed 7–16–15; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\17JYN1.SGM 17JYN1

Agencies

[Federal Register Volume 80, Number 137 (Friday, July 17, 2015)]
[Notices]
[Page 42539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17520]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Siegfried 
USA, LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Siegfried USA, LLC applied to be registered as a manufacturer 
of certain basic classes of controlled substances. The Drug Enforcement 
Administration (DEA) grants Siegfried USA, LLC registration as a 
manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated February 5, 2015, and 
published in the Federal Register on February 11, 2015, 80 FR 7634, 
Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 
08070 applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted to this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Siegfried USA, LLC to manufacture 
the basic classes of controlled substances is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Dihydromorphine (9145).....................  I
Hydromorphinol (9301)......................  I
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.

    Dated: July 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-17520 Filed 7-16-15; 8:45 am]
 BILLING CODE 4410-09-P